DK573082A - Anthracyklinglycosid-praeparater, deres anvendelse og fremstilling - Google Patents
Anthracyklinglycosid-praeparater, deres anvendelse og fremstilling Download PDFInfo
- Publication number
- DK573082A DK573082A DK573082A DK573082A DK573082A DK 573082 A DK573082 A DK 573082A DK 573082 A DK573082 A DK 573082A DK 573082 A DK573082 A DK 573082A DK 573082 A DK573082 A DK 573082A
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- anthracycling
- lycoside
- preparations
- anthracycline glycoside
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
- A61K47/544—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/24—Condensed ring systems having three or more rings
- C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/258,016 US4419348A (en) | 1981-04-27 | 1981-04-27 | Anthracycline glycoside compositions, their use and preparation |
| US25801681 | 1981-04-27 | ||
| US8200464 | 1982-04-14 | ||
| PCT/US1982/000464 WO1982003769A1 (en) | 1981-04-27 | 1982-04-14 | Anthracycline glycoside compositions,their use and preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK573082A true DK573082A (da) | 1982-12-23 |
| DK163277B DK163277B (da) | 1992-02-17 |
| DK163277C DK163277C (da) | 1992-07-06 |
Family
ID=22978743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK573082A DK163277C (da) | 1981-04-27 | 1982-12-23 | Anthracyklinglycosid-kardiolipinkompleks indkapslet i liposomer, fremgangsmaade til fremstilling heraf samt terapeutisk praeparat indeholdende dette |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US4419348A (da) |
| EP (1) | EP0077377B1 (da) |
| JP (1) | JPS58500715A (da) |
| AU (1) | AU552812B2 (da) |
| DE (1) | DE3268367D1 (da) |
| DK (1) | DK163277C (da) |
| WO (1) | WO1982003769A1 (da) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4612370A (en) * | 1982-04-02 | 1986-09-16 | The Regents Of The University Of California | Lipid-saccharide reaction products |
| CA1237670A (en) * | 1983-05-26 | 1988-06-07 | Andrew S. Janoff | Drug preparations of reduced toxicity |
| US5059591B1 (en) * | 1983-05-26 | 2000-04-25 | Liposome Co Inc | Drug preparations of reduced toxicity |
| EP0153955A1 (en) * | 1983-09-06 | 1985-09-11 | Health Research, Inc. | Liposome delivery method for decreasing the toxicity of an antitumor drug |
| US4771130A (en) * | 1984-02-17 | 1988-09-13 | William Cohen | Target-entrapped drugs |
| PT78628B (en) * | 1984-05-02 | 1986-06-18 | Liposome Co Inc | Pharmaceutical composition with reduced toxicity |
| US5077056A (en) * | 1984-08-08 | 1991-12-31 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
| US5736155A (en) * | 1984-08-08 | 1998-04-07 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
| IE58981B1 (en) * | 1985-10-15 | 1993-12-15 | Vestar Inc | Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles |
| US4797285A (en) * | 1985-12-06 | 1989-01-10 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | Lipsome/anthraquinone drug composition and method |
| US5244678A (en) * | 1986-01-14 | 1993-09-14 | Ire-Celltarg S.A. | Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes |
| US5043107A (en) * | 1986-08-21 | 1991-08-27 | Vestar Research, Inc. | Preparation small unilamellar vesicles including polyene antifungal antibiotics |
| JPH0825869B2 (ja) * | 1987-02-09 | 1996-03-13 | 株式会社ビタミン研究所 | 抗腫瘍剤包埋リポソ−ム製剤 |
| US6406713B1 (en) | 1987-03-05 | 2002-06-18 | The Liposome Company, Inc. | Methods of preparing low-toxicity drug-lipid complexes |
| MX9203808A (es) * | 1987-03-05 | 1992-07-01 | Liposome Co Inc | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. |
| US5616334A (en) * | 1987-03-05 | 1997-04-01 | The Liposome Company, Inc. | Low toxicity drug-lipid systems |
| WO1988007852A1 (en) * | 1987-04-06 | 1988-10-20 | Innovative Therapeutics Corporation | Liposome entrapped magnesium |
| US4863739A (en) * | 1987-05-19 | 1989-09-05 | Board Of Regents, The University Of Texas System | Liposome compositions of anthracycline derivatives |
| AU598958B2 (en) * | 1987-11-12 | 1990-07-05 | Vestar, Inc. | Improved amphotericin b liposome preparation |
| US4946683A (en) * | 1987-11-18 | 1990-08-07 | Vestar, Inc. | Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes |
| EP0396626A1 (en) * | 1988-01-19 | 1990-11-14 | Board Of Regents, The University Of Texas System | Glycosides, liposomal compositions thereof, and methods for their use |
| US6060080A (en) * | 1990-07-16 | 2000-05-09 | Daiichi Pharmaceutical Co., Ltd. | Liposomal products |
| CA2046997C (en) * | 1990-07-16 | 2000-12-12 | Hiroshi Kikuchi | Liposomal products |
| DK0555229T3 (da) * | 1990-07-31 | 1996-08-19 | Liposome Co Inc | Akkumulation af aminosyrer og peptider i liposomer |
| WO1994005259A1 (en) * | 1992-09-02 | 1994-03-17 | Georgetown University | Method of encapsulating anthracycline glycosides in liposomes |
| US7314637B1 (en) | 1999-06-29 | 2008-01-01 | Neopharm, Inc. | Method of administering liposomal encapsulated taxane |
| EP1355634B8 (en) | 2000-11-09 | 2009-03-04 | Neopharm, Inc. | Sn-38 lipid complexes and methods of use |
| WO2003030864A1 (en) | 2001-05-29 | 2003-04-17 | Neopharm, Inc. | Liposomal formulation of irinotecan |
| AU2003268087A1 (en) * | 2002-08-23 | 2004-03-11 | Ian Ma | Liposomal gemcitabine compositions for better drug delivery |
| BRPI0407096A (pt) | 2003-02-03 | 2006-01-24 | Neopharm Inc | Taxano encapsulado em lipossomo estável, estéril e filtrável e outros fármacos antineoplásicos |
| KR100651728B1 (ko) * | 2004-11-10 | 2006-12-06 | 한국전자통신연구원 | 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법 |
| EP3046542B1 (en) * | 2013-09-19 | 2021-01-06 | Council of Scientific and Industrial Research | Synergistic liposomal formulation for the treatment of cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3993754A (en) * | 1974-10-09 | 1976-11-23 | The United States Of America As Represented By The United States Energy Research And Development Administration | Liposome-encapsulated actinomycin for cancer chemotherapy |
| US4263428A (en) * | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| IL55431A (en) * | 1978-08-24 | 1982-07-30 | Yeda Res & Dev | Anthracycline type antibiotics,their preparation and pharmaceutical compositions comprising them |
-
1981
- 1981-04-27 US US06/258,016 patent/US4419348A/en not_active Expired - Lifetime
-
1982
- 1982-04-14 EP EP82901664A patent/EP0077377B1/en not_active Expired
- 1982-04-14 DE DE8282901664T patent/DE3268367D1/de not_active Expired
- 1982-04-14 JP JP57501656A patent/JPS58500715A/ja active Granted
- 1982-04-14 WO PCT/US1982/000464 patent/WO1982003769A1/en not_active Ceased
- 1982-04-14 AU AU85209/82A patent/AU552812B2/en not_active Expired
- 1982-12-23 DK DK573082A patent/DK163277C/da active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0077377B1 (en) | 1986-01-08 |
| WO1982003769A1 (en) | 1982-11-11 |
| JPS58500715A (ja) | 1983-05-06 |
| AU8520982A (en) | 1982-11-24 |
| AU552812B2 (en) | 1986-06-19 |
| DK163277C (da) | 1992-07-06 |
| US4419348A (en) | 1983-12-06 |
| DK163277B (da) | 1992-02-17 |
| EP0077377A4 (en) | 1983-09-26 |
| JPH0526767B2 (da) | 1993-04-19 |
| EP0077377A1 (en) | 1983-04-27 |
| DE3268367D1 (en) | 1986-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK573082A (da) | Anthracyklinglycosid-praeparater, deres anvendelse og fremstilling | |
| IT1179359B (it) | Composizione per rigenerare il collageno del tessuto connettivo della pelle, e suo procedimento di preparazione | |
| SE8504945D0 (sv) | Pharmaceutical compositions containing anthracycline glycosides | |
| AU469541B2 (en) | Improvements in or relating to broadband waveguide circulators | |
| MY8500995A (en) | Enzyme derivatives for use in the treatment of venous thrombosis, compositions containing them and their preparation | |
| IT1147806B (it) | Complessi di ciclodestrine e glicosidi cardiaci per uso terapeutico e procedimento di preparazione | |
| SE8202439L (sv) | 4'-jodderivat av antracyklinglykosider | |
| AU5396279A (en) | Cardiac glycoside composition | |
| SE8602405D0 (sv) | Ny formulering | |
| IT8223892A0 (it) | Composizione di antralina migliorata e suo uso nel trattamento di malattie della pelle. | |
| DK0482097T3 (da) | Tensidpræparater og fremgangsmåder | |
| AU460396B2 (en) | Improvements in or relating to heart valves | |
| IT1180748B (it) | Eteri amminociclopentilici,procedimento per prepararli e composizione farmaceutica che li comprende | |
| DE3785046A1 (da) | ||
| FI853095L (fi) | Foerfarande foer aotervinning av en gelbildande polysackarid, aotervunnen polysackarid och gel bildad daermed. | |
| IL42108A (en) | The preparation of human acth and its fragments | |
| IT7967067A0 (it) | Zione antibiotici amminoglicosidici e procedimento per la poro prepara | |
| CA982477A (en) | Composition therapeutique active contre l'obesite et la cellulite et son mode de preparation | |
| IT1187642B (it) | Emoglobina a ridotti rischi da virus e procedimento per prepararla | |
| IT1121005B (it) | Procedimento e composizione per il trattamento della dissenteria suina | |
| IT7924358A0 (it) | Antibiotici, procedimento per laloro preparazione, e coltura biologicamente pura per impiego in tale procedimento. | |
| AU4683272A (en) | Improvements in or relating to games racquets | |
| EP0004823A3 (en) | Process for the preparation of oside derivatives, derivatives so obtained and their biological applications | |
| JPS5661400A (en) | Novel anthracycline glycoside and its manufacture | |
| EP0415198A3 (en) | Ketophosphamidyl glycosides, process for their preparation and their use as pharmaceutical agents |